Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 166.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"MAIT T-cell: 6.1"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	11.4	0.1	2.0	6.0	4.0	0.1	4.6	1.6	2.1	18.2	3.5	0.4	0.2	6.3	0.0	0.4	0.2	11.8	0.7	1.0	2.5	1.0	0.2	1.3	3.2	6.0	2.7	8.8	0.5	0.1	1.1	166.5	3.1	0.3	0.6	0.3	1.1	0.0	0.1	0.4	0.5	4.3	1.8	1.6	0.5	0.9	10.4	1.8	0.3	0.0	3.5	11.6	0.5	3.0	16.8	2.5	6.5	0.1	18.7	38.3	0.0	42.7	3.5	14.2	35.5	0.0	0.0	0.0	0.0	154.2	30.0	0.0	0.2	1.4	15.5	1.9	0.6	0.2	25.1	0.0	2.9	0.0	33.2	47.0	0.0	94.3	2.9	27.1	0.0	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	4.8	4.4	0.4	44.1	0.5	28.4	5.0	0.0	0.7	2.5	0.1	0.1	0.0	50.9	16.9	93.2	86.2	0.0	0.5	0.0	70.7	0.1	32.3	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	2.0	4.0	1.6	2.1	1.0	2.5	6.0	2.7	3.1	1.8	10.4	3.0	0.5	0.0	1.9	22.5	0.3	1.5	0.4	3.0	0.0	2.1	1.7	3.6	2.3	0.0	0.5	0.0	102.2	14.0	0.5	0.7	0.0	8.0	10.9	10.7	16.6	1.6	0.0	0.0	7.4	1.1	400.8	34.5	0.5	1.8	49.5	7.8	2.5	0.2	15.5	6.7	19.0	1.0	4.1	0.6	3.1	1.7	16.8	0.8	1.8	14.0	9.0	3.3	1.0	99.0	52.2	2.2	0.1	0.7	0.3	1.0	0.7	0.4	6.5	30.5	0.0	5.1	13.4	6.0	5.0	0.0	0.6	129.2	4.7	28.1	0.9	0.5
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014257-39020352	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	12.3	36.2	3.1	31.1	3.2	31.4	12.3	3.1	4.0	23.1	3.5	20.2	14.0	22.6	51.7	22.7	56.0	18.4	24.0	3.0	3.5	6.0	7.0	20.6	57.8	5.0	3.6	38.2	5.1	10.5	3.8	11.6	5.1	25.9	33.1	3.4	22.1	36.1	2.7	19.8	17.4	30.8	4.5	36.5	18.1	29.4	3.9	25.2	15.2	11.3	67.8	27.6	17.3	6.5	39.4	38.1	6.3	73.9	40.2	82.6	32.4	28.3	54.9	41.0	54.5	36.8	43.7	115.5	18.6	56.1	26.2	39.4	6.5	120.2	39.5	44.3	32.0	111.8	1.6	30.6	43.5	73.4	107.1	90.5	68.1	54.0	13.3	20.4	23.0	0.9	69.9	142.3	83.0	0.4	29.6	39.8	9.8	0.5	82.8	51.1	16.9	96.6	27.2	51.4	1.9	4.9	40.9	0.2	21.7	15.9	0.2	26.8	11.9	21.8	37.1	11.9	12.4	38.6	42.7	9.5	66.9	47.1	58.8	86.6	104.4	277.0	309.1	220.6	212.6	241.6	164.7	276.9	106.9	249.1	54.0	196.9	14.1	196.9	247.8	86.9	168.9	173.6	3.1	3.2	3.1	4.0	3.0	3.5	5.0	3.6	5.1	4.5	3.9	6.5	3.3	3.2	16.2	0.0	68.8	25.2	45.4	44.1	24.5	0.2	16.4	8.9	23.0	28.6	18.4	7.3	0.0	4.3	60.2	56.6	0.0	31.6	3.2	11.0	16.4	9.6	26.4	57.2	0.0	1.3	1.4	26.5	5.6	15.6	57.0	78.6	30.0	1.2	61.9	0.0	0.0	17.8	28.5	49.0	37.3	9.3	57.8	34.2	44.4	0.0	65.1	24.4	117.4	0.5	0.0	11.5	16.6	38.0	55.4	18.9	3.2	1.3	13.6	0.8	26.3	11.9	20.1	1.5	1.5	9.7	16.3	1.9	67.7	53.5	18.8	41.9
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		7900000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	41.6	5.8	15.8	10.4	15.5	0.2	29.8	13.1	12.1	26.0	33.2	49.1	4.9	46.6	10.1	24.9	63.2	19.3	14.3	17.1	15.2	9.7	1.0	6.6	3.6	53.2	30.1	35.2	16.1	2.7	20.8	2.2	23.2	33.8	4.6	3.2	23.8	21.3	6.3	34.9	18.3	32.6	32.3	4.6	19.0	5.0	26.3	5.7	24.6	9.0	3.1	32.5	25.8	23.4	0.0	7.6	27.6	79.2	113.6	6.0	0.9	12.8	41.9	3.2	2.7	0.0	0.0	0.1	7.8	21.8	1.7	0.0	5.6	2.7	1.1	0.0	3.4	0.0	2.3	0.0	0.6	0.3	0.2	19.7	1.8	1.7	0.2	25.7	0.0	0.0	0.1	0.0	0.6	2.1	0.2	1.4	7.0	0.0	6.9	0.2	12.3	0.0	0.7	0.1	8.2	11.7	0.1	0.5	0.3	8.1	3.4	0.4	0.0	4.5	7.3	0.1	4.2	0.0	0.0	0.0	9.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	15.5	13.1	12.1	17.1	15.2	53.2	30.1	23.2	32.3	26.3	23.4	9.6	0.0	0.5	71.8	0.0	21.2	3.1	3.6	112.1	0.6	3.7	17.3	1.1	1.5	0.7	5.5	0.0	4.8	0.2	0.0	0.0	0.1	1.4	12.6	10.5	5.6	1.8	0.0	8.8	0.0	4.3	55.4	0.5	11.7	0.0	5.7	3.3	0.1	0.8	0.0	2.5	0.0	0.0	0.3	5.5	3.3	84.8	1.0	10.6	6.5	0.0	12.2	0.0	24.1	0.7	0.3	0.0	47.8	0.6	3.3	0.0	0.0	0.3	0.5	0.0	18.0	13.5	1.5	3.2	11.5	11.1	1.9	0.8	1.1	0.0	0.9
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066961-77126155	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 60.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 170.3;Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 89.8;Paneth cells: 72.6;Proximal enterocytes: 75.6;Undifferentiated cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"OE19: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	6.7	12.2	8.5	10.9	7.9	2.7	4.9	6.4	8.6	13.5	3.5	60.5	60.7	10.0	5.7	31.6	10.8	36.3	7.2	8.5	8.7	15.1	52.1	4.8	1.9	11.7	8.2	13.2	5.6	1.0	5.1	2.8	12.5	16.0	49.9	3.8	7.7	8.9	1.6	3.1	52.4	11.3	9.9	3.5	47.9	21.5	7.9	2.8	4.7	1.7	2.7	15.4	10.5	8.1	0.8	12.5	8.6	7.8	32.0	30.4	0.7	11.8	22.9	13.4	10.0	6.9	3.6	0.4	7.7	24.5	14.4	0.5	3.8	1.0	6.4	0.5	0.8	2.1	0.5	0.9	7.9	0.2	0.4	16.1	1.4	22.6	5.2	18.8	14.4	5.1	0.2	0.0	26.9	19.9	1.8	0.3	6.6	106.6	9.3	2.0	27.0	0.4	4.6	16.4	0.5	13.5	1.0	2.7	5.9	5.7	1.7	0.1	23.9	25.4	12.3	34.8	1.3	0.8	1.7	0.1	13.1	0.3	5.7	0.0	0.2	0.0	1.3	0.3	0.1	0.0	0.1	0.5	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.0	0.7	8.5	7.9	6.4	8.6	8.5	8.7	11.7	8.2	12.5	9.9	7.9	8.1	1.6	0.0	0.5	4.2	1.0	1.7	0.3	2.2	0.0	3.1	0.5	1.8	1.7	24.3	10.3	23.9	0.0	0.1	3.4	170.3	1.9	10.3	1.1	1.9	5.9	2.4	22.3	5.7	4.6	32.7	0.4	7.6	80.0	3.5	0.0	10.2	2.9	40.4	0.9	1.7	6.7	89.8	10.2	1.6	1.8	1.3	12.5	1.2	7.2	1.0	0.3	5.8	5.2	11.6	0.7	22.4	72.6	4.5	0.9	2.0	75.6	9.9	11.1	2.1	0.0	8.3	4.1	0.5	2.3	2.5	0.9	0.0	1.5	5.3	69.2	2.4
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410329-46413564	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 36.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0;Distal tubular cells: 39.2;Granulosa cells: 25.7;Leydig cells: 70.8;Peritubular cells: 57.9;Theca cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 18.5;AN3-CA: 22.2;HSkMC: 19.6;K-562: 20.3;RH-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	4.1	16.3	4.1	2.7	3.8	0.7	8.8	3.9	2.6	13.9	7.5	3.3	0.9	13.9	10.5	1.3	22.9	4.2	24.7	3.6	3.9	11.2	0.7	4.4	0.9	5.2	7.4	36.8	13.6	9.1	12.9	6.7	5.3	6.4	1.2	1.3	10.8	7.5	2.1	3.1	2.2	6.5	4.8	2.3	2.2	5.9	4.2	5.6	9.0	2.4	0.8	7.5	7.3	4.4	1.9	0.1	18.5	22.2	4.8	6.0	8.9	9.6	0.0	2.1	0.9	0.1	0.1	0.2	12.5	7.6	0.4	0.2	0.1	15.0	1.0	0.0	9.4	0.0	0.2	1.0	16.0	0.1	0.1	19.6	0.0	5.2	15.2	0.3	0.1	0.1	20.3	0.0	6.8	0.0	0.0	1.3	13.3	0.0	0.0	0.7	24.8	0.0	16.1	0.1	2.9	0.1	0.1	0.1	0.1	14.2	0.1	4.7	1.7	1.2	4.9	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	3.8	3.9	2.6	3.6	3.9	5.2	7.4	5.3	4.8	4.2	4.4	0.7	0.0	1.1	1.3	0.0	0.9	6.5	1.5	0.0	0.4	1.8	19.3	27.0	7.2	4.0	11.0	0.0	7.5	0.1	0.0	39.2	14.8	0.4	15.0	13.9	1.2	0.0	0.0	0.0	1.1	10.0	17.3	0.0	3.9	1.3	25.7	1.1	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.9	2.9	70.8	0.6	1.8	1.0	0.0	14.6	0.0	1.5	0.1	3.6	0.0	57.9	0.0	3.7	0.0	1.2	2.4	0.5	13.1	12.3	8.3	0.4	5.5	0.0	0.1	2.1	0.2	32.7	0.0	0.8
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194760-65211473	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		13000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	49.8	0.8	0.2	9.5	0.2	0.1	21.9	0.3	0.3	44.9	0.1	20.3	2.3	13.8	3.6	11.0	15.8	36.8	27.4	0.2	0.2	1.0	1.6	2.9	1.6	0.2	0.2	7.5	3.0	0.3	0.7	2.5	0.2	3.1	6.9	0.5	9.4	4.8	15.5	14.0	22.6	51.0	0.2	0.6	8.3	12.1	0.2	1.8	2.4	32.9	0.8	26.9	28.1	0.2	0.0	0.0	0.0	0.0	4.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	8.1	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	0.9	0.4	0.5	2.1	0.0	0.4	1.8	0.0	0.0	0.2	0.1	0.0	0.1	1.7	1.2	42.9	1.5	0.0	0.0	0.3	0.0	0.0	138.1	4.1	1.7	0.0	0.1	2.2	0.1	0.1	0.0	0.6	0.1	2.0	0.0	11.9	7.1	231.5	1.7	1.8	1.9	0.0	0.2	0.0	1.0	0.3	0.0	0.0	57.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	14.7	6.6	0.6	0.3	0.1	6.1	0.0	1.6	83.5	0.2	0.0
COL11A1	"CO11A1, COLL6, DFNA37, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 20.1;retina: 9.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 83.9;Excitatory neurons: 99.5;Oligodendrocyte precursor cells: 557.4;Theca cells: 139.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 116.9;BJ: 43.2;BJ hTERT+ SV40 Large T+ RasG12V: 85.3;HBF TERT88: 48.7;HSkMC: 142.5;SuSa: 60.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		640000		"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Endoplasmic reticulum"		"HPA058335: AB_2683682"	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	0.6	0.6	4.3	0.3	3.1	0.0	0.4	1.6	4.6	0.9	2.8	0.4	0.1	0.5	0.1	0.0	0.0	3.1	0.0	2.4	2.5	0.1	0.0	0.3	0.1	2.5	3.7	0.6	0.7	0.2	3.3	20.1	2.2	0.2	0.3	9.6	1.5	0.8	0.1	1.4	0.1	0.3	1.0	0.5	0.1	1.4	2.2	0.0	0.1	0.1	0.0	0.2	0.1	2.1	0.0	0.8	116.9	0.0	4.6	5.9	0.0	43.2	16.1	23.3	85.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	142.5	0.0	1.1	0.0	17.7	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	8.1	0.0	0.1	0.0	7.4	0.0	15.2	0.0	0.1	0.0	0.0	0.1	0.0	60.5	0.0	0.1	0.0	0.6	27.0	0.0	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.1	1.6	4.6	2.4	2.5	2.5	3.7	2.2	1.0	2.2	2.1	0.0	0.0	2.2	83.9	0.0	1.8	0.0	0.0	0.0	9.4	0.1	4.2	0.5	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	21.0	0.1	0.9	2.2	0.0	0.0	99.5	0.0	0.8	18.7	0.0	0.0	2.5	8.3	0.0	0.0	0.3	0.0	32.9	0.0	0.0	0.0	1.3	4.0	1.2	0.2	10.6	29.0	0.0	29.8	0.0	557.4	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	2.6	0.5	0.8	0.0	1.1	0.3	0.2	139.6	0.0	0.0
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981769-46005050	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 796.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 578.3;Fibroblasts: 816.1;Leydig cells: 353.0;Peritubular cells: 251.3;Smooth muscle cells: 324.4;Theca cells: 246.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1157.2;ASC TERT1: 2331.5;BJ: 927.1;HHSteC: 1025.3;HSkMC: 1711.4;U-138 MG: 1297.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 46.8"	"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA		250000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (4.54e-4)"	285.9	50.1	15.7	153.3	9.0	0.7	173.9	33.9	20.4	499.3	32.1	796.8	73.3	556.3	24.6	91.1	411.5	194.4	155.6	10.3	14.9	66.1	48.3	140.3	37.5	23.1	18.4	491.4	57.8	29.1	117.8	287.1	21.5	246.8	40.5	3.4	97.7	142.3	85.4	123.4	217.7	177.9	11.3	70.7	230.5	32.8	14.9	30.7	92.6	39.5	16.6	478.7	284.7	9.7	2.9	20.2	31.2	99.6	1157.2	2331.5	3.9	927.1	586.3	231.7	80.7	16.2	62.8	0.1	75.1	522.2	183.6	4.3	13.5	2.3	19.5	0.5	14.9	0.0	3.7	5.2	1025.3	0.3	2.2	1711.4	1.0	578.6	7.8	20.9	5.6	0.2	0.7	0.6	60.9	1.4	0.3	3.2	22.4	13.4	263.2	0.1	19.5	4.3	1.6	11.1	1.0	39.9	87.6	1.1	17.9	10.4	4.2	4.2	0.5	1297.6	86.7	362.7	358.1	0.6	0.4	0.4	464.1	6.9	116.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	9.0	33.9	20.4	10.3	14.9	23.1	18.4	21.5	11.3	14.9	9.7	74.6	0.0	5.8	26.1	2.5	122.2	11.0	1.5	18.2	18.9	9.2	35.9	42.7	5.7	4.4	9.2	0.0	11.6	2.3	0.6	3.9	23.2	4.6	20.9	578.3	50.6	1.8	0.0	27.1	3.3	18.6	816.1	6.1	16.1	1.3	48.7	101.0	13.4	22.4	15.2	8.2	0.3	0.0	3.3	134.7	18.6	353.0	7.8	147.7	40.3	2.0	18.7	0.0	30.7	2.4	6.1	2.6	251.3	3.5	6.3	2.1	10.3	1.0	4.3	184.1	152.3	324.4	2.6	6.2	5.5	89.9	20.8	13.7	246.5	1.4	3.8
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645242-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 225.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 150.2;Oligodendrocytes: 299.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 250.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 116.1;ASC TERT1: 131.4;hTERT-RPE1: 108.2;Karpas-707: 97.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	46.2	35.9	22.6	25.4	33.9	31.8	34.7	28.0	26.7	75.1	20.6	39.6	29.3	46.0	36.2	25.9	39.8	57.8	51.8	21.6	27.0	80.5	70.0	32.3	22.8	32.6	27.5	87.4	46.7	60.7	25.6	39.2	33.2	40.2	33.1	16.8	32.8	54.2	13.3	20.6	35.0	64.7	25.9	31.3	32.1	13.9	30.3	8.2	225.9	33.2	17.0	46.3	38.6	38.6	0.6	2.1	2.1	0.1	116.1	131.4	0.5	35.3	55.6	12.8	26.5	2.0	0.9	0.4	27.2	59.0	15.7	1.0	2.4	2.8	12.0	31.4	4.4	28.4	1.5	17.7	25.6	4.9	37.0	69.6	6.5	15.0	3.7	108.2	6.0	0.1	27.1	97.0	29.4	1.2	0.5	14.1	2.5	0.2	5.2	4.3	0.0	0.6	26.7	13.2	2.4	0.3	10.2	0.4	28.2	25.8	12.3	28.6	21.3	51.9	4.9	0.8	11.5	7.9	0.9	0.3	32.2	21.6	33.5	32.0	71.3	45.1	27.3	49.6	27.6	5.4	20.3	24.0	51.8	7.4	17.6	24.6	250.5	25.9	47.5	14.8	22.2	40.6	22.6	33.9	28.0	26.7	21.6	27.0	32.6	27.5	33.2	25.9	30.3	38.6	46.6	12.8	12.5	150.2	11.7	19.4	25.7	21.3	9.6	12.7	12.1	27.9	27.2	42.9	13.9	47.8	29.2	12.1	40.8	9.3	17.6	22.7	5.0	6.6	43.3	27.1	13.8	7.2	24.0	10.7	1.8	123.8	10.7	8.6	38.0	43.1	51.0	48.3	54.0	10.1	31.3	7.9	24.4	56.0	44.9	9.0	72.4	39.4	78.2	131.2	33.7	43.4	39.1	44.7	299.6	11.7	9.5	73.0	11.9	12.4	42.4	56.0	9.7	16.3	52.6	71.1	67.8	5.6	3.4	2.8	13.1	6.0	23.8	38.6	12.2	13.5
DHRS1	"FLJ25430, MGC20204, SDR19C1"	ENSG00000157379	"Dehydrogenase/reductase 1"	Q96LJ7	14	24290598-24299780	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 68.9;liver: 61.2"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 178.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000599, HPA076886"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Centrosome, Cytosol"	"HPA000599: AB_1078655, HPA076886: "	"unprognostic (2.08e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.18e-5)"	"prognostic favorable (6.83e-4)"	"unprognostic (3.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.88e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-1)"	12.4	14.8	2.0	2.8	2.1	4.4	13.3	2.3	2.8	17.6	2.7	16.3	21.5	11.5	5.8	68.9	9.4	5.3	5.4	2.0	2.4	15.0	61.2	9.7	4.4	2.4	2.1	7.0	7.7	13.5	8.8	3.5	2.3	10.1	6.6	1.2	26.2	7.4	2.9	40.7	19.8	5.7	2.3	10.5	11.4	5.5	2.1	4.8	11.7	2.8	9.5	8.9	25.4	2.7	16.6	4.0	4.2	1.7	9.4	10.0	1.1	5.9	12.7	13.4	14.6	1.7	15.7	7.7	2.5	9.3	2.2	14.0	3.2	26.5	6.6	5.4	3.6	2.4	9.1	27.2	4.5	4.8	1.9	8.9	15.9	3.4	2.5	11.2	10.2	6.5	4.9	7.4	11.4	7.0	1.8	1.8	0.7	13.4	6.1	6.0	3.0	10.8	10.5	6.4	3.8	2.7	8.2	11.1	3.0	3.0	5.8	1.4	4.0	1.1	2.6	1.7	2.0	4.1	3.5	3.8	4.9	4.1	1.3	15.1	9.0	18.4	6.5	10.2	7.2	9.9	7.2	6.2	11.1	6.3	7.0	4.0	5.9	5.0	6.2	6.8	12.3	5.2	2.0	2.1	2.3	2.8	2.0	2.4	2.4	2.1	2.3	2.3	2.1	2.7	17.8	22.4	17.1	8.5	18.4	32.9	26.9	89.9	28.5	12.3	32.4	27.3	19.0	50.1	36.1	35.0	18.8	48.3	26.2	59.6	39.2	27.1	21.7	14.2	6.7	17.1	19.2	16.2	6.9	30.4	9.5	16.5	19.4	18.0	6.3	14.6	14.6	105.4	28.1	15.2	9.2	39.8	40.7	14.6	18.0	34.8	20.2	17.0	46.2	4.7	15.2	16.5	24.7	7.1	14.2	64.1	50.3	20.7	21.8	17.9	178.8	74.8	22.6	47.7	26.3	10.4	16.3	27.3	14.0	80.5	45.7	26.1	23.4	13.7	41.3	35.9
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561785-184582408	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Angiogenesis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 51.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 38.1;Breast myoepithelial cells: 50.8;Enteroendocrine cells: 71.5;Intestinal goblet cells: 43.3;Squamous epithelial cells: 44.3;Undifferentiated cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.8;HaCaT: 40.2;OE19: 28.3;SK-BR-3: 30.9;T-47d: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					NA	NA		100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.7	0.7	3.0	3.7	2.7	0.1	10.4	5.8	4.1	22.7	1.0	10.3	6.4	10.1	1.8	30.6	4.0	2.8	1.9	2.9	2.4	5.8	0.9	3.4	0.9	5.7	3.4	8.3	14.9	1.1	2.0	5.7	6.1	10.0	10.9	0.5	31.7	3.5	0.5	51.5	6.3	3.8	2.3	1.0	22.8	0.9	4.0	0.7	0.9	0.4	2.4	4.0	20.9	2.7	6.6	2.3	14.8	1.6	4.5	0.3	28.8	1.1	1.9	2.2	1.2	2.0	0.2	0.0	2.8	6.3	1.0	40.2	5.4	1.9	0.6	0.2	1.1	0.0	0.3	0.0	0.3	0.0	0.2	1.2	13.0	1.8	0.2	0.7	0.0	0.0	0.0	0.0	1.0	17.6	0.0	6.4	1.4	28.3	2.5	1.5	9.0	0.0	0.0	5.8	1.9	2.2	1.2	30.9	1.3	7.8	20.5	0.1	0.0	3.6	5.1	1.8	2.5	0.0	0.0	0.1	0.3	0.0	14.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	5.8	4.1	2.9	2.4	5.7	3.4	6.1	2.3	4.0	2.7	0.9	3.2	2.7	11.1	0.2	24.1	7.6	5.3	17.1	0.9	38.1	50.8	1.8	2.8	4.6	0.0	0.0	10.1	1.1	21.5	1.9	0.5	0.6	3.7	4.0	1.4	71.5	0.0	4.6	1.6	18.7	6.9	27.0	7.5	4.5	2.1	1.8	0.0	23.5	15.2	5.8	43.3	10.2	0.3	9.8	0.4	2.8	2.4	0.0	1.0	0.8	0.1	0.0	5.0	0.3	3.2	7.2	6.0	0.0	6.0	1.7	0.2	1.4	1.0	0.0	4.5	2.9	0.4	0.6	44.3	35.8	16.3	0.8	1.6	55.0	20.7
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4;smooth muscle: 26.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.1;hippocampal formation: 2.4"	HPA059739	Uncertain				"Secreted to blood"	NA	NA	108000000	56000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	5.8	0.2	0.9	5.2	0.9	0.0	10.1	0.4	0.9	15.2	0.0	3.5	0.5	31.4	8.5	3.6	4.8	22.3	4.9	0.3	1.4	0.7	0.2	4.0	1.5	0.6	0.5	3.0	2.5	0.7	0.5	23.1	0.6	1.9	2.5	6.4	4.7	5.8	4.4	2.8	0.9	26.4	0.2	0.4	1.0	1.5	1.0	0.5	2.8	7.5	1.5	15.5	3.6	0.7	0.0	0.0	0.0	0.0	192.2	202.3	0.4	82.8	167.8	16.6	25.4	0.0	0.0	0.0	0.6	31.3	0.0	0.1	0.0	5.1	8.0	0.0	0.0	0.1	1.2	0.0	19.5	0.0	0.0	66.2	1.2	28.1	5.2	209.1	0.1	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.5	0.0	9.0	0.2	0.1	0.0	84.3	167.3	3.1	41.4	0.4	0.0	0.1	0.0	37.5	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.9	0.3	1.4	0.6	0.5	0.6	0.2	1.0	0.7	3.9	0.0	0.0	5.5	0.2	4.5	0.1	7.0	0.0	1.8	0.3	0.5	0.4	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.2	6.7	3.4	67.6	6.4	4.9	0.0	13.3	0.2	1.9	43.4	0.0	6.2	0.0	0.0	1.4	0.0	0.9	1.7	0.3	1.4	0.0	0.0	2.6	4.1	8.4	0.8	3.6	17.8	0.0	57.5	0.0	0.5	4.2	1.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	2.0	0.0	4.7	25.2	2.3	0.4	0.4	4.3	1.8	0.8	1.3	0.2	0.0
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549125-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 6.7;naive CD8 T-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2"	"Group enriched"	"Detected in many"	4	"olfactory bulb: 12.4;white matter: 3.1"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	157.3	7.6	5.9	12.7	7.7	1.0	97.3	5.2	9.0	63.4	6.4	32.7	6.2	31.1	3.2	42.4	26.8	46.2	292.8	7.0	4.9	8.7	3.7	29.2	8.4	5.3	5.3	5.8	8.6	3.0	2.3	80.3	4.8	29.1	11.8	0.6	39.4	8.8	47.7	72.5	19.8	14.7	4.1	6.0	22.3	46.7	6.9	14.2	63.7	48.9	5.6	79.6	56.7	4.4	0.0	1.4	50.9	0.0	384.0	51.7	23.8	124.9	98.2	122.4	80.4	8.1	0.3	0.0	5.9	264.3	0.2	0.2	0.0	0.5	22.9	0.1	0.1	100.7	1.9	0.0	26.0	0.2	311.6	221.9	2.0	19.3	0.0	0.2	0.0	8.6	0.8	0.9	0.6	0.3	5.2	0.6	12.2	0.0	0.7	0.2	0.0	0.5	0.9	0.1	3.0	2.4	0.5	90.3	0.1	13.6	0.2	0.3	0.1	0.1	0.1	139.2	0.1	0.2	0.0	0.0	1.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.2	6.7	1.3	0.0	3.7	0.0	0.2	0.0	0.5	0.0	0.9	5.9	7.7	5.2	9.0	7.0	4.9	5.3	5.3	4.8	4.1	6.9	4.4	92.7	0.0	1.5	1.6	3.6	30.8	0.8	10.5	2.2	0.0	1.7	1.9	8.8	0.0	12.3	7.3	2.1	7.8	1.9	0.1	0.0	0.0	3.8	2.9	84.4	43.8	0.0	1.7	0.6	0.2	4.8	458.4	6.1	2.7	23.6	0.6	47.8	0.4	3.6	0.0	0.6	0.0	0.0	1.9	49.8	12.1	170.9	4.5	39.2	26.2	0.3	1.2	0.0	30.7	0.3	0.3	0.0	227.2	1.6	1.2	2.7	0.1	1.4	0.4	13.1	29.7	26.4	3.4	13.5	2.0	28.8	6.2	5.3	0.2	0.0	1.1
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FGF14	"FHF4, SCA27"	ENSG00000102466	"Fibroblast growth factor 14"	Q92915	13	101710804-102402457	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.4;cervix: 7.3"	"Group enriched"	"Detected in many"	31	"Excitatory neurons: 1994.2;Inhibitory neurons: 2754.3;Oligodendrocyte precursor cells: 2271.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.0;SH-SY5Y: 5.8;U-87 MG: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049828			Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"		"HPA049828: AB_2680901"	"unprognostic (2.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.80e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.48e-2)"	0.5	1.2	3.2	0.0	2.6	0.0	0.3	11.4	5.1	7.3	0.0	0.2	0.1	0.1	0.4	0.5	2.7	0.4	1.5	2.5	7.7	0.1	0.4	1.4	0.0	2.2	1.1	0.1	0.3	0.0	3.3	0.1	2.2	0.1	0.1	1.6	0.3	0.1	0.1	0.4	0.4	0.0	1.6	0.0	0.7	1.0	4.5	0.0	0.2	0.1	0.0	0.2	0.5	2.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.6	11.4	5.1	2.5	7.7	2.2	1.1	2.2	1.6	4.5	2.1	0.5	3.2	1.5	74.4	0.0	0.5	0.5	0.2	2.2	33.2	0.3	1.8	7.4	2.8	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.3	18.3	4.4	0.4	0.3	19.2	0.0	1994.2	0.0	0.1	9.6	2.0	1.4	0.0	0.1	0.4	2.5	0.1	32.0	2754.3	1.0	6.1	0.0	0.0	35.2	2.5	0.1	1.8	36.5	0.0	5.2	3.1	2271.0	32.3	0.1	0.0	0.0	0.0	0.8	0.0	0.3	53.8	2.7	0.0	1.9	1.9	2.5	5.2	0.3	0.6	0.0	0.2	0.1	0.0	0.1
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1725.9;placenta: 2928.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	151.1	31.4	37.8	131.9	44.8	0.6	76.5	36.3	51.2	135.9	85.9	444.0	33.8	156.1	61.3	251.6	174.5	187.1	410.9	38.9	41.1	42.9	1725.9	785.7	37.3	37.7	39.8	110.0	26.0	19.3	26.2	2928.1	43.5	105.6	237.2	6.0	67.0	428.9	37.7	52.7	103.4	722.6	36.2	14.3	127.2	25.8	112.1	133.8	40.4	148.4	23.9	361.7	87.1	35.3	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	44.8	36.3	51.2	38.9	41.1	37.7	39.8	43.5	36.2	112.1	35.3	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	Q9NY28	12	4720400-4851927	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 31.3;testis: 13.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 95.2;Intestinal goblet cells: 47.0;Late spermatids: 150.2"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.2;glioma: 1.8;pancreatic cancer: 0.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Karpas-707: 23.4;U-266/84: 7.6"					"Not detected"	"Not detected"			"HPA012638, HPA073461"	Supported		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	0.4	0.6	3.2	1.8	3.3	0.0	0.6	2.7	5.1	0.5	2.0	14.0	5.7	0.3	0.1	0.1	0.6	0.0	2.5	3.2	2.8	0.4	0.2	0.3	0.2	3.4	3.2	0.7	0.2	0.0	2.8	0.1	3.3	0.4	31.3	0.2	0.4	0.3	0.1	0.2	12.6	0.8	2.9	0.5	0.5	13.5	3.3	0.0	0.2	0.0	0.0	0.4	0.3	4.1	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	23.4	0.0	0.0	0.0	0.1	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	3.2	3.3	2.7	5.1	3.2	2.8	3.4	3.2	3.3	2.9	3.3	4.1	0.1	6.4	0.5	1.3	0.5	0.0	0.0	0.1	0.6	2.1	0.1	2.3	4.5	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	95.2	0.5	0.1	0.5	6.6	0.0	1.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	47.0	0.0	0.0	0.0	150.2	1.5	0.1	0.0	3.7	0.2	0.5	0.0	15.1	7.4	0.2	0.6	2.6	0.0	0.1	1.0	1.0	0.0	0.6	6.6	0.7	0.1	12.3	8.3	0.0	0.0	0.0	0.8	0.3	2.2	0.0
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 188.5;Langerhans cells: 203.6;Macrophages: 117.6;monocytes: 203.0;NK-cells: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.6;HDLM-2: 72.9;TIME: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		19000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	38.5	20.9	17.6	52.7	22.8	73.8	32.4	21.0	22.6	45.9	14.1	73.7	14.7	77.8	15.1	18.6	36.9	24.1	24.2	17.2	19.3	8.8	6.9	62.6	29.9	24.8	22.1	13.3	5.6	2.5	4.9	8.8	22.3	38.3	33.1	2.7	15.3	39.3	7.7	12.2	32.2	63.8	22.8	41.3	25.3	3.4	26.7	18.7	15.8	11.1	19.2	38.8	27.4	27.6	3.7	2.9	20.9	22.3	71.6	33.3	2.4	32.9	20.0	7.8	14.1	1.3	0.3	0.2	10.2	30.9	19.7	0.2	7.9	1.1	4.7	72.9	6.4	8.8	6.2	0.4	27.9	5.7	28.3	23.4	1.0	44.5	7.8	14.0	62.5	22.6	0.4	5.0	17.4	7.9	27.9	15.2	20.1	0.3	10.7	18.9	44.1	1.0	1.6	1.8	5.6	11.3	4.4	2.2	3.6	42.2	2.3	24.0	127.3	10.7	24.8	9.6	28.0	7.8	2.2	12.7	11.0	35.0	2.5	268.6	360.9	540.3	168.4	162.5	89.1	24.4	114.3	108.2	208.3	24.5	47.0	74.7	657.0	125.5	124.9	18.5	132.2	414.0	17.6	22.8	21.0	22.6	17.2	19.3	24.8	22.1	22.3	22.8	26.7	27.6	11.9	3.2	25.4	4.6	22.3	13.4	2.5	14.7	1.8	0.3	46.9	19.0	2.6	2.8	30.9	5.5	0.0	3.8	66.9	14.7	0.0	21.2	0.7	1.8	33.9	13.3	8.4	58.7	1.1	1.3	3.3	54.3	11.7	2.1	52.6	1.9	16.1	0.9	188.5	0.0	0.8	42.4	14.2	83.2	203.6	2.3	18.0	117.6	62.2	2.8	203.0	21.4	180.2	3.0	28.6	5.2	16.1	25.9	22.8	16.0	4.0	1.1	64.3	0.5	46.0	44.7	43.2	0.9	6.4	0.9	10.2	3.4	75.5	10.9	45.3	3.3
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988987-104064183	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.3;Early spermatids: 41.2;Fibroblasts: 55.9;Leydig cells: 55.9;Peritubular cells: 51.9;Skeletal myocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 69.3;BJ hTERT+: 89.4;HSkMC: 63.2;hTERT-RPE1: 51.9;RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	16.9	10.9	4.2	5.2	4.9	1.5	19.5	2.6	5.1	29.6	11.2	17.6	5.8	27.4	21.6	7.5	22.3	35.8	15.4	4.8	3.7	4.3	2.7	10.2	6.0	2.9	3.1	41.6	4.5	6.6	9.6	9.4	3.1	13.3	11.4	1.0	7.7	16.0	3.2	4.1	7.7	21.8	2.8	1.6	8.4	6.8	3.7	2.2	26.3	11.5	5.8	20.8	18.9	4.4	0.3	0.6	0.7	22.2	28.3	69.3	0.5	32.0	89.4	8.3	10.5	0.4	0.2	0.9	1.8	37.5	0.4	0.1	0.4	11.9	7.0	1.6	10.0	0.6	11.2	0.2	12.7	0.9	0.5	63.2	0.7	10.0	13.8	51.9	4.4	0.6	0.4	1.3	36.5	0.3	0.8	0.5	2.7	0.1	6.7	1.0	33.6	0.2	45.5	0.4	1.3	1.7	33.5	0.8	0.4	2.4	6.0	0.5	0.7	13.2	6.2	1.3	1.9	3.9	0.8	0.3	1.0	0.7	1.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	4.9	2.6	5.1	4.8	3.7	2.9	3.1	3.1	2.8	3.7	4.4	8.0	0.0	4.6	2.9	0.3	2.8	4.2	2.4	0.0	0.8	1.0	26.3	3.9	1.5	0.1	0.0	2.1	4.1	0.4	0.0	0.0	0.1	41.2	0.6	8.3	7.5	1.8	0.0	10.2	0.0	0.8	55.9	1.1	0.4	0.0	0.1	20.7	0.3	0.6	0.0	10.5	1.3	0.0	0.6	2.8	11.5	55.9	0.4	3.6	4.7	0.6	0.5	0.0	1.0	2.6	0.3	0.0	51.9	1.2	1.4	0.0	0.0	0.1	0.5	6.6	25.2	18.0	1.1	1.1	0.2	2.4	1.4	0.6	10.7	0.0	0.1
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
IL17RD	"FLJ35755, IL-17RD, IL17RLM, SEF"	ENSG00000144730	"Interleukin 17 receptor D"	Q8NFM7	3	57089982-57170306	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039577, HPA043550"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA039577: AB_2676580, HPA043550: AB_2678546"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.11e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (2.92e-9)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (9.58e-3)"	1.9	0.8	4.7	0.9	5.7	0.0	7.4	5.2	4.0	6.0	28.0	5.9	0.4	13.5	10.6	2.4	6.4	3.3	1.9	5.5	6.5	5.7	0.2	0.6	0.3	8.9	8.8	7.4	0.9	9.4	2.3	0.3	5.5	5.1	1.8	0.3	6.0	8.5	0.6	2.0	1.0	12.0	6.2	2.5	1.2	9.7	4.8	0.3	0.5	2.6	0.5	2.8	3.3	6.5	4.0	0.8	25.0	67.9	0.1	0.6	4.0	0.4	0.2	0.3	0.8	0.5	1.9	0.0	0.2	1.4	5.3	0.2	4.8	1.0	0.8	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.1	1.0	2.6	0.0	0.5	16.6	1.1	0.6	0.0	0.1	1.4	0.5	0.0	0.1	39.2	2.2	1.9	0.0	9.1	0.0	5.2	1.0	0.6	102.0	1.0	1.5	2.9	8.1	0.9	0.0	0.7	1.3	1.6	1.2	4.2	0.0	0.0	0.1	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	5.7	5.2	4.0	5.5	6.5	8.9	8.8	5.5	6.2	4.8	6.5	1.4	0.0	2.3	11.4	0.0	0.9	2.0	3.1	0.0	0.1	1.5	14.0	1.6	1.5	2.4	0.0	0.0	0.3	0.1	0.1	0.0	3.1	17.9	0.5	5.5	4.0	0.0	0.0	0.6	0.2	0.1	10.1	0.0	1.0	0.0	2.0	1.1	0.1	0.1	0.0	0.9	0.3	2.0	0.0	1.2	23.7	11.5	0.6	0.0	15.0	0.0	0.6	0.0	7.5	2.1	0.7	0.7	25.9	0.0	2.9	0.0	5.0	1.8	0.0	0.0	4.8	1.3	10.6	7.5	1.1	0.9	0.1	0.3	6.5	0.3	0.7
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 76.1;Skeletal myocytes: 93.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"spinal cord: 56.9"						"Secreted - unknown location"	NA	NA		37000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.9	9.2	1.8	0.7	1.8	0.1	18.0	2.6	2.3	23.8	2.5	1.5	0.5	2.0	0.5	9.7	4.9	38.3	18.3	1.9	3.6	2.7	7.7	25.4	1.3	3.9	2.3	5.3	7.9	5.6	10.3	33.4	4.3	4.0	2.5	0.1	11.7	4.4	4.5	13.2	0.5	4.1	3.5	4.0	7.2	2.5	2.2	0.9	8.4	14.9	4.3	17.8	10.0	6.5	4.2	0.3	0.0	0.0	208.3	138.7	0.0	65.8	67.7	29.3	18.7	0.0	2.4	0.0	0.3	345.3	13.9	70.9	0.0	24.1	46.0	0.0	0.0	21.3	0.6	0.0	21.7	0.0	0.0	59.3	1.5	16.8	46.6	55.3	76.8	0.0	1.5	0.7	311.8	0.0	0.0	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.8	24.0	33.2	27.3	0.1	8.3	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	2.6	2.3	1.9	3.6	3.9	2.3	4.3	3.5	2.2	6.5	1.9	3.2	0.5	5.5	0.1	4.0	0.1	1.3	0.6	1.8	4.2	19.0	0.5	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.5	4.5	0.5	7.7	1.2	0.0	0.0	3.6	0.2	0.8	76.1	5.6	1.1	0.0	0.0	8.6	0.5	0.7	5.0	6.7	0.0	0.0	0.0	4.7	2.1	0.0	0.8	5.4	13.1	0.0	0.5	0.0	2.0	5.0	1.1	0.0	8.2	0.6	0.2	0.0	0.1	0.0	0.7	0.0	93.0	4.8	11.6	8.4	0.7	2.4	0.8	0.4	1.2	0.0	0.2
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210503-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 105.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 63.3;Microglial cells: 67.5;Oligodendrocytes: 135.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 75.6;ASC diff: 11.3;ASC TERT1: 16.9;WM-115: 19.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: AB_2681331"	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	5.6	2.1	18.4	6.0	87.7	0.5	3.4	39.2	42.2	13.1	0.0	9.0	2.4	14.6	6.4	5.1	8.7	16.2	11.4	29.0	64.1	4.1	1.2	2.5	5.0	59.2	62.3	13.6	0.9	0.1	2.2	0.1	54.7	6.6	4.2	0.5	5.8	7.3	0.6	1.4	4.2	14.7	18.3	2.7	3.6	2.6	75.3	8.3	2.0	1.7	4.7	5.2	4.8	105.0	3.0	0.3	75.6	0.1	11.3	16.9	0.0	7.6	4.3	0.0	0.0	0.3	2.2	0.0	0.3	2.4	2.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.3	0.0	2.2	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.4	0.0	1.1	0.4	1.4	0.0	0.0	0.0	0.2	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	87.7	39.2	42.2	29.0	64.1	59.2	62.3	54.7	18.3	75.3	105.0	0.1	0.0	0.0	63.3	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	2.5	0.2	0.0	0.0	0.8	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.4	1.1	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.9	3.7	0.2	1.8	67.5	0.0	0.0	0.0	19.6	135.6	0.6	0.0	7.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.1	1.2	0.3	0.3	0.2	0.3	0.0	0.0	0.4	0.0	0.0
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78979947	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"monocytes: 27.2;T-cells: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 862.9;SK-BR-3: 2270.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	NA	NA		7100000000	"Cluster 32: T-cells - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	192.8	218.6	51.2	75.0	91.4	48.6	109.5	95.6	62.3	188.8	159.8	210.8	312.9	121.4	45.2	114.2	155.6	240.8	311.4	46.6	81.4	103.1	68.5	182.8	52.7	145.6	88.3	155.6	79.1	107.8	134.9	147.0	116.8	114.3	92.6	10.0	498.7	154.2	20.0	54.0	260.9	80.2	104.3	76.8	315.6	70.1	89.8	48.8	102.0	20.4	25.3	125.0	119.0	152.5	499.0	255.3	7.2	11.2	157.3	181.4	147.9	55.7	49.0	371.3	725.7	107.5	862.9	2.8	372.7	33.5	361.7	200.1	53.6	203.7	11.5	1.2	319.0	33.8	206.0	481.0	387.7	0.4	31.6	305.8	111.5	197.5	12.6	83.8	9.9	68.7	3.4	1.5	87.7	62.8	151.2	6.0	13.0	163.7	170.7	100.1	209.9	4.8	155.5	352.6	235.1	267.4	52.7	2270.3	754.5	14.0	57.5	16.1	16.3	245.5	169.8	7.1	225.8	0.8	2.2	3.7	332.1	96.8	263.7	0.8	17.7	4.9	12.0	27.2	25.0	4.7	43.3	17.9	7.6	2.4	68.4	33.0	1.2	9.4	14.7	0.6	26.0	25.1	51.2	91.4	95.6	62.3	46.6	81.4	145.6	88.3	116.8	104.3	89.8	152.5	88.0	189.1	144.3	9.8	5.6	31.1	146.8	462.5	60.3	37.2	60.5	43.1	180.7	127.2	306.2	139.8	6.2	179.1	3.4	629.8	17.6	275.0	7.2	77.4	118.7	26.8	168.2	4.4	0.3	136.5	336.0	284.6	257.9	126.9	13.3	316.5	46.8	45.8	88.3	74.0	5.3	328.7	309.3	36.8	23.7	37.1	282.7	36.0	81.8	8.4	27.9	80.8	2.1	11.6	33.9	132.4	584.1	266.3	3.5	72.4	931.4	49.2	123.9	24.3	177.5	80.5	119.6	4.5	2.1	83.8	27.3	108.9	15.4	228.3	400.5	128.2
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 17.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 5497.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 19.1;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	0.7	3.4	11.4	0.8	14.1	0.0	1.4	0.5	15.4	3.0	0.0	2.5	0.4	1.2	0.3	0.4	0.5	0.8	2.1	14.4	9.6	0.3	1.1	0.8	0.7	7.8	10.7	0.6	0.3	1.7	4.0	0.0	5.7	0.6	0.7	17.1	0.6	1.6	0.3	0.2	0.8	1.3	4.6	0.6	0.5	0.2	8.1	0.6	2.3	0.7	0.7	0.7	2.0	9.2	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	20.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.1	0.5	15.4	14.4	9.6	7.8	10.7	5.7	4.6	8.1	9.2	0.2	0.0	1.3	498.2	0.2	0.1	0.0	1.4	0.0	35.5	4.2	3.0	1.2	0.0	1.4	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.9	0.3	10.5	1.4	0.0	0.0	1171.8	0.0	0.0	5.6	0.0	0.9	0.0	0.1	0.0	0.0	0.1	8.4	1274.6	0.0	0.0	0.0	1.9	0.2	2.1	0.4	1.8	49.6	0.0	93.6	0.0	5497.5	221.3	0.3	0.0	1.5	0.1	0.1	0.0	0.7	0.0	99.7	0.0	2.0	0.7	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029817	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1;salivary gland: 68.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 162.1;SK-MEL-30: 201.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	NA	NA		41000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	10.0	1.7	2.3	3.8	1.7	2.3	7.4	2.1	3.8	8.1	27.2	4.0	2.4	6.8	0.7	2.9	8.6	1.6	7.5	2.5	1.9	35.1	1.6	1.9	1.9	0.6	2.8	1.2	4.6	10.3	2.9	1.5	0.4	4.1	2.1	0.3	68.7	5.5	1.1	16.4	9.9	1.2	0.5	1.1	1.7	3.4	6.5	2.9	3.1	1.0	1.6	3.2	7.3	2.0	162.1	34.6	0.4	1.2	4.8	6.0	4.0	2.8	1.5	5.2	6.3	9.8	23.6	4.5	33.3	5.6	4.5	49.6	1.8	0.1	2.3	7.4	10.8	5.6	7.9	4.1	30.5	0.8	30.8	33.0	4.3	4.3	0.4	0.2	0.8	8.9	4.3	30.5	3.1	9.8	9.3	0.0	3.6	6.9	22.5	13.4	5.3	2.0	0.8	1.5	3.1	11.3	32.5	2.8	201.4	3.8	9.5	4.8	1.2	1.2	26.8	5.5	19.9	5.3	46.0	4.5	3.9	9.5	0.2	0.0	0.1	0.0	0.2	0.2	0.8	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	2.3	1.7	2.1	3.8	2.5	1.9	0.6	2.8	0.4	0.5	6.5	2.0	0.8	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	21.1	20.6	0.0	0.0	1.8	14.7	0.0	0.2	1.0	0.0	0.0	28.3	0.0	3.2	6.1	0.6	0.0	0.0	0.0	5.7	0.3	3.7	0.0	4.4	0.0	3.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.6	0.0	0.0	0.0	0.0	66.4	0.0	0.0	1.7	0.0	0.0	0.5	1.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 56.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.3;Proximal enterocytes: 16.1;Skeletal myocytes: 12.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 67.0;eosinophil: 144.5"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 144.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;Hep G2: 7.6;HMC-1: 6.1;REH: 3.2;THP-1: 2.8"									HPA051433	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	2.1	1.8	1.2	1.5	1.2	2.4	1.9	0.3	1.8	6.9	1.1	3.9	5.0	3.1	2.3	2.4	3.6	1.4	2.4	1.3	0.6	8.4	56.3	1.9	1.2	0.9	0.9	9.1	7.2	0.3	3.8	1.7	0.7	6.6	1.8	0.3	1.5	1.7	0.9	3.1	8.5	0.8	0.4	4.9	2.3	1.2	1.0	1.0	2.2	0.4	1.1	6.0	4.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	6.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.3	2.2	0.0	7.6	0.0	0.1	6.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.0	3.2	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	67.0	1.8	144.5	0.1	0.6	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.8	1.2	1.2	0.3	1.8	1.3	0.6	0.9	0.9	0.7	0.4	1.0	0.6	0.1	0.0	0.5	0.7	0.1	0.5	0.6	0.2	0.6	1.6	0.4	0.6	0.4	2.8	0.2	1.8	0.0	0.1	0.0	1.9	1.9	0.6	0.0	0.1	2.0	0.1	1.2	0.0	0.0	2.0	0.1	2.0	0.0	0.1	2.5	0.4	0.4	8.3	1.0	0.0	0.0	3.4	0.0	1.3	1.2	0.3	3.4	1.5	3.6	1.0	3.0	0.9	0.0	0.0	0.0	0.6	5.3	1.9	0.0	0.5	16.1	4.9	0.2	0.0	0.0	12.9	1.1	0.3	0.2	0.3	0.1	0.3	1.1	0.3	5.1	0.3
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Fibroblasts: 186.2;Leydig cells: 74.6;Peritubular cells: 70.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"AN3-CA: 189.4;BJ hTERT+: 159.1;HSkMC: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA052801: AB_2681956"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	34.1	4.2	2.5	3.9	3.5	0.2	51.9	2.8	3.0	27.8	1.9	9.0	0.9	15.8	10.3	3.0	23.3	13.4	11.1	2.3	2.3	1.3	0.7	4.7	1.2	2.7	2.6	42.9	6.9	9.0	7.4	9.0	2.5	5.4	3.1	0.6	13.1	6.7	18.4	11.0	2.6	26.0	2.4	0.8	6.2	6.5	2.9	3.8	33.0	38.0	2.0	6.5	12.0	3.3	0.0	17.7	1.0	189.4	5.6	2.5	13.8	4.6	159.1	7.5	31.3	1.0	0.2	0.0	0.9	2.5	24.7	0.0	11.6	0.9	3.7	0.2	14.5	0.0	5.3	4.1	14.6	0.0	0.0	86.9	0.1	9.2	0.1	0.0	13.0	1.6	0.0	2.4	1.1	12.5	0.2	0.4	9.9	0.7	3.6	0.0	0.2	0.4	1.0	11.4	0.6	1.2	1.4	1.7	3.3	11.4	0.6	0.0	2.6	0.2	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	3.5	2.8	3.0	2.3	2.3	2.7	2.6	2.5	2.4	2.9	3.3	15.5	0.0	3.6	2.3	0.3	13.3	0.5	4.3	0.6	0.6	2.9	3.3	4.5	1.5	2.8	0.0	0.0	14.9	0.7	0.4	0.0	4.1	36.0	2.4	5.4	4.1	1.2	0.0	1.1	7.1	19.9	186.2	0.5	4.7	0.0	0.3	1.4	0.2	3.5	0.0	3.5	1.3	2.0	0.0	14.6	6.7	74.6	1.6	10.6	1.9	1.6	1.4	0.0	3.0	1.3	3.1	0.1	70.7	0.2	1.9	0.4	0.1	0.2	0.4	0.0	8.0	10.7	0.8	1.9	0.6	9.9	9.7	1.7	1.5	0.4	0.5
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116909916-116990353	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.2;Cardiomyocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 146.8;WM-115: 111.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved					NA	NA		340000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA017074: AB_1855888"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-2)"	11.6	21.1	3.2	10.1	3.5	0.0	10.6	3.3	4.8	14.9	8.3	40.6	11.3	31.2	10.6	21.2	23.9	17.2	48.8	3.3	2.6	4.0	6.6	6.6	2.5	2.8	4.5	15.9	13.3	6.3	2.9	5.0	2.2	18.0	21.7	1.4	18.5	23.6	2.9	17.8	14.0	46.6	4.6	3.1	10.5	5.3	4.1	5.3	6.9	3.9	6.2	20.1	15.1	3.2	40.0	10.3	18.4	42.8	3.2	8.3	2.6	2.8	4.4	15.4	5.8	7.2	8.7	0.0	35.7	10.6	12.7	69.7	41.4	74.4	9.7	0.4	25.1	2.9	24.0	11.1	1.1	0.1	3.9	37.3	66.0	2.0	36.4	21.9	30.0	4.2	16.5	0.2	23.5	50.9	0.0	5.5	21.5	3.3	0.1	0.0	100.6	0.2	51.3	32.4	9.0	20.8	80.0	55.9	22.9	32.1	48.8	12.3	77.6	22.4	33.2	37.2	25.1	0.0	0.1	0.1	146.8	0.0	111.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.5	3.3	4.8	3.3	2.6	2.8	4.5	2.2	4.6	4.1	3.2	2.3	3.2	5.9	15.0	0.5	66.2	13.4	25.6	22.2	6.5	10.9	11.9	79.4	10.0	12.2	3.7	0.0	0.8	0.3	20.6	1.9	31.2	4.8	10.2	19.3	12.1	13.9	0.0	13.6	31.8	5.5	32.0	10.7	16.9	0.0	22.1	3.9	11.1	4.4	0.0	7.4	18.2	14.2	8.8	9.7	6.3	19.3	4.7	8.8	3.7	3.1	1.2	0.0	31.2	0.9	27.9	11.1	30.1	0.0	15.1	15.8	1.2	13.6	0.2	19.7	48.5	12.5	0.8	5.2	20.3	45.3	0.8	1.4	28.3	26.3	17.4
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.3;skin 1: 152.5;urinary bladder: 175.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.9;Glandular and luminal cells: 191.9;granulocytes: 208.0;Hepatic stellate cells: 61.8;Macrophages: 55.3;Suprabasal keratinocytes: 58.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.9;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 113.7;ASC TERT1: 89.5;BJ: 115.2;BJ hTERT+: 156.0;HEL: 73.6;HMC-1: 298.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	12.8	2.9	3.1	10.5	3.2	9.0	6.7	4.2	4.8	5.8	5.5	108.3	10.8	6.1	2.2	67.3	43.2	9.6	12.6	7.4	5.5	9.3	3.0	11.3	4.6	6.5	5.2	2.0	1.8	2.0	4.8	2.2	6.3	21.1	24.2	0.7	4.3	6.1	2.1	152.5	17.7	16.1	6.7	8.0	20.5	0.9	7.0	2.2	3.2	4.0	11.6	175.0	15.9	11.9	0.3	0.5	0.4	0.0	113.7	89.5	0.0	115.2	156.0	1.0	1.1	0.0	0.2	4.2	5.4	19.7	0.3	7.1	0.4	10.5	0.9	0.0	0.2	73.6	0.6	0.0	32.9	5.2	298.4	46.1	1.2	5.7	0.3	0.0	42.3	0.1	0.1	0.3	2.3	0.0	0.2	6.6	1.6	0.0	0.5	0.3	1.4	8.6	14.7	0.0	0.5	0.6	0.6	9.5	0.2	0.5	0.3	8.4	1.0	0.7	0.6	1.7	0.1	0.3	0.2	0.0	0.4	31.6	0.3	28.9	12.1	23.3	0.0	13.1	0.0	2.4	0.0	0.0	20.0	3.5	0.1	0.0	5.2	2.8	10.2	1.4	0.2	21.9	3.1	3.2	4.2	4.8	7.4	5.5	6.5	5.2	6.3	6.7	7.0	11.9	0.9	0.0	6.6	0.0	5.9	9.9	2.6	7.7	0.0	0.1	1.1	1.4	1.6	4.3	2.2	42.3	0.0	0.1	0.2	0.1	0.0	0.6	0.1	109.9	10.4	24.7	1.8	18.7	0.8	0.5	0.3	10.7	2.0	191.9	208.0	0.1	61.8	0.8	26.1	0.0	0.5	0.6	4.1	15.5	20.7	0.3	1.5	55.3	3.6	16.9	11.7	0.0	7.2	1.0	0.1	0.6	0.6	0.0	0.3	2.8	0.0	0.0	0.8	0.1	0.0	1.4	3.6	0.0	0.2	18.2	58.7	0.4	3.4	0.1	1.0	0.8
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519099	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 19.3;Fibroblasts: 27.0;Leydig cells: 18.0;Peritubular cells: 15.8;Skeletal myocytes: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.9;BJ: 22.7;fHDF/TERT166: 27.5;hTERT-RPE1: 23.2;U-87 MG: 27.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		88000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	13.1	2.2	2.6	3.6	4.6	0.1	8.8	3.0	2.1	23.0	1.8	33.6	1.9	39.7	3.9	5.7	17.0	12.9	17.6	1.8	2.1	3.6	1.7	9.1	1.3	3.9	2.6	14.5	1.8	0.3	17.6	1.9	4.0	8.8	2.8	1.1	3.4	12.8	3.6	5.6	8.7	20.1	2.2	11.1	9.8	2.6	3.6	2.0	3.8	2.8	0.5	10.6	15.9	2.1	0.1	1.4	0.5	0.0	3.3	26.9	0.0	22.7	5.5	3.7	4.6	0.4	0.0	1.2	0.3	27.5	1.1	0.0	0.0	0.0	1.9	0.1	0.3	5.6	1.5	0.0	5.2	0.1	9.6	12.3	0.0	5.4	0.0	23.2	0.0	0.7	0.2	0.3	0.6	0.1	0.1	0.5	0.9	0.0	0.2	0.7	1.2	0.3	2.5	0.0	2.9	0.4	0.4	0.0	0.5	0.5	0.4	1.2	7.9	1.0	1.3	1.1	3.8	0.4	0.0	0.1	27.8	0.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.6	3.0	2.1	1.8	2.1	3.9	2.6	4.0	2.2	3.6	2.1	3.5	3.2	0.6	4.2	0.3	1.9	0.3	0.3	0.0	5.3	0.8	1.1	2.8	0.0	0.1	0.0	2.1	0.1	0.4	0.8	1.9	0.1	0.6	1.5	19.3	3.3	0.0	0.0	1.5	0.0	0.1	27.0	2.0	0.9	0.0	0.5	2.2	0.0	1.2	3.3	1.1	0.4	0.0	1.0	3.8	1.3	18.0	2.0	1.8	2.8	0.7	2.1	0.0	0.0	0.3	0.1	0.3	15.8	0.3	0.3	4.6	0.2	0.7	1.9	0.0	32.1	6.8	0.9	1.1	0.4	1.8	0.0	0.5	0.9	1.4	0.2
TCEAL8	"MGC45400, WEX3"	ENSG00000180964	"Transcription elongation factor A like 8"	Q8IYN2	X	103252995-103255192	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059115	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA059115: AB_2683909"	"unprognostic (1.51e-2)"	"unprognostic (4.56e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (8.53e-6)"	"unprognostic (3.71e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.32e-2)"	42.9	62.6	51.9	36.3	53.1	29.3	60.0	55.0	69.6	67.2	53.8	47.9	30.5	58.3	131.1	38.8	45.3	57.1	93.1	53.1	54.6	69.4	42.7	43.9	47.6	53.4	52.2	69.4	40.9	71.0	56.5	62.2	53.9	59.2	49.5	33.2	61.5	56.1	18.8	39.3	40.4	63.2	55.1	45.8	42.0	42.9	53.4	71.9	71.3	32.0	45.7	57.3	36.5	55.9	49.2	26.4	110.9	51.8	161.9	269.3	53.2	104.9	154.7	90.6	141.0	20.6	94.5	25.8	68.2	120.7	157.7	32.1	19.6	120.0	116.5	0.4	61.5	111.2	34.5	30.8	98.8	114.4	105.6	184.9	68.0	79.5	0.0	190.3	123.9	75.3	135.0	23.8	223.6	0.0	98.2	43.9	123.2	4.4	52.7	37.1	152.8	7.6	124.7	36.4	57.7	75.4	58.3	18.1	130.8	105.7	33.9	38.0	83.1	53.5	71.0	164.4	35.2	26.2	49.8	1.1	86.7	61.0	87.6	73.7	31.9	20.0	66.3	29.3	76.6	62.4	78.1	71.4	58.2	52.6	84.5	73.5	3.0	120.6	23.2	101.3	109.5	54.5	51.9	53.1	55.0	69.6	53.1	54.6	53.4	52.2	53.9	55.1	53.4	55.9	72.3	51.3	66.7	6.8	32.7	60.8	83.9	169.4	68.9	52.3	70.5	69.2	76.6	104.4	89.4	97.5	10.4	188.8	48.5	27.5	273.9	137.8	6.8	46.2	71.8	85.0	78.5	33.2	10.3	109.4	176.3	93.9	29.6	49.7	69.6	76.2	169.6	102.5	98.7	50.5	10.0	133.7	81.4	90.6	81.1	17.2	125.9	52.4	120.9	10.3	71.4	110.4	104.0	7.1	11.3	68.2	49.2	121.9	27.2	51.3	73.5	276.2	60.1	37.5	85.5	80.6	77.4	5.6	4.0	47.6	59.5	134.9	45.1	68.1	78.7	79.5
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 216.7;heart muscle: 167.9;smooth muscle: 251.4;tongue: 214.6"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	216.7	1.2	15.4	5.2	19.6	10.6	26.8	13.8	13.0	2.1	5.0	58.1	2.2	26.8	1.6	6.0	2.5	10.4	167.9	12.2	24.5	0.7	0.3	1.3	1.1	22.3	25.3	4.1	22.8	35.7	14.3	0.2	19.9	9.0	8.7	7.5	46.5	5.7	77.2	2.9	3.3	251.4	21.7	0.3	8.6	8.7	28.0	3.6	27.0	214.6	4.0	3.5	5.8	20.0	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	19.6	13.8	13.0	12.2	24.5	22.3	25.3	19.9	21.7	28.0	20.0	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0